SCHEMBL14837807

SCHEMBL14837807

CCCCCOc1ccc2c(c1)CCC(=O)N2.O=c1ccc2cc(OCc3cc(NCc4ccc(OC(F)F)cc4)no3)ccc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 9/20 0.37
▸ MAOB P27338 9/20 0.37
▸ FAAH O00519 1/20 0.36
▸ PDE3B Q13370 3/20 0.36
▸ PDE3A Q14432 3/20 0.36
▸ TP53 P04637 1/20 0.34
▸ DRD2 P14416 4/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HTR7 P34969 1/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ ABCC4 O15439 1/20 0.33
▸ CACNA1F O60840 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15671743 0.89 MAOB (0.37) MAOAMAOBPDE3BPDE3ATP53
SCHEMBL14816294 0.83 TP53 (0.40) MAOBPDE3BPDE3ATP53DRD2
SCHEMBL13111961 0.68 MAOB (0.65) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL14816097 0.67 MAOB (0.42) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL12359302 0.67 MAOB (0.70) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL31718445 0.63 MAOB (0.67) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL14800873 0.62 POLB (0.48) MAOAMAOBPDE3BPDE3ATP53
SCHEMBL31718471 0.62 RAB9A (0.56) MAOAMAOBMEN1CYP1A2KMT2A
SCHEMBL6585538 0.62 MAOB (0.68) MAOAMAOBPDE3BPDE3ADRD2
SCHEMBL15854760 0.62 DRD2 (0.52) MAOBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760856-A1 SELECTIVE NR2B ANTAGONISTS Bristol-Myers Squibb Company (US) 2014-08-06 — — EP disclosed
WO-2013049119-A1 SELECTIVE NR2B ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-04 — — WO disclosed
Send feedback